Libya vs Papua New Guinea: Prevalence rate of diabetes in adults
Libya
15.9
in 2014
Papua New Guinea
14.8
in 2014
Libya rank
18th
Papua New Guinea rank
21st
Prevalence rate of diabetes in adults over time
- Libya
- Papua New Guinea
How they compare
Libya currently reports 15.9 against 14.8 in Papua New Guinea, a difference of 1.1.
That makes Libya's figure about 1.1 times Papua New Guinea's.
Across all 35 years both countries report, Libya has been ahead every year.
Libya ranks 18th and Papua New Guinea ranks 21st of 190 countries.
Libya has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Libya | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 8.94 | 6.46 | 2.48 | Libya |
| 1990s | 10.37 | 8.78 | 1.59 | Libya |
| 2000s | 12.82 | 11.57 | 1.25 | Libya |
| 2010s | 15.28 | 14.02 | 1.26 | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Libya or Papua New Guinea?
- Libya, at 15.9 against 14.8 in Papua New Guinea as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Libya and Papua New Guinea?
- 1.1, with Libya ahead.
- How many years of comparable data are there for Libya and Papua New Guinea?
- 35 years are reported by both, from 1980 to 2014.
- How do Libya and Papua New Guinea rank globally for prevalence rate of diabetes in adults?
- Libya ranks 18th and Papua New Guinea ranks 21st of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.